Leth-Petersen, S; Petersen, IN; Jensen, AA; Bundgaard, C; Bæk, M; Kehler, J; Kristensen, JL. 5-HT2A/5-HT2C receptor pharmacology and intrinsic clearance of N-benzylphenethylamines modified at the primary site of metabolism ACS Chem. Neurosci., 16 Nov 2016, 7 (11), 1614–1619. 684 kB. https://doi.org/10.1021/acschemneuro.6b00265 #12a
CPM · Cyclopropylmescaline
3C-AL · 4-Allyloxy-3,5-dimethoxyamphetamine
2,5-Dimethoxy-4-propanonylamphetamine · DOCOE
N-AL-M · N-Allyl-3,4,5-trimethoxyphenethylamine
N-Cyclopropyl-3,4,5-trimethoxyphenethylamine · N-cPr-M
4-(1-Methylallyloxy)-3,5-dimethoxyphenethylamine · sec-MAL · sec-Methallylescaline · MAL-2
4-Methallyloxy-2,6-dimethoxyphenethylamine · ψ-2C-O-3
4-Allyloxy-2,6-dimethoxyamphetamine · ψ-MALM
2,5-Dimethoxy-4-methallyloxyphenethylamine · 2C-O-3
4-Allyloxy-2,5-dimethoxyamphetamine · MALM
2C-THF3 · 4-(Tetrahydrofuran-3-yl)-2,5-dimethoxyphenethylamine
3-Methoxy-4-propoxymethcathinone · POMMC
N-Acetyl-2,5-dimethoxy-4-methylamphetamine · N-Acetyl-DOM